Meningococcal Infection clinical trials

Explore recruiting meningococcal infection clinical trials.

Recruiting meningococcal infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Meningococcal Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A parallel-group, prevention, Phase III, modified double-blind, 2-arm, study to investigate the immunogenicity and describe the safety of a quadrivalent meningococcal conjugate vaccine (MenACYW conjugate vaccine) compared with Nimenrix® when administered in a 1+1 schedule in healthy infants and toddlers at 6 and 12 months of age

Finland, Poland, Germany, Romania, Denmark, Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase IIIb, Open-label, Multi-center Study to Evaluate the Immunogenicity and Safety of a Booster Dose and Describe the Immune Persistence of MenACYW Conjugate Vaccine with 5- and/or 10-year Booster Doses in Children and Adolescents who had been Primed with MenACYW Conjugate Vaccine as Toddlers

Germany, Finland, Hungary, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Meningococcal Infection trials by city

Meningococcal Infection in Toronto Meningococcal Infection in Vancouver Meningococcal Infection in Montreal Meningococcal Infection in Calgary Meningococcal Infection in Edmonton Meningococcal Infection in Ottawa Meningococcal Infection in Winnipeg Meningococcal Infection in Quebec City Meningococcal Infection in Hamilton Meningococcal Infection in Kitchener Meningococcal Infection in London Meningococcal Infection in Halifax Meningococcal Infection in New York Meningococcal Infection in Los Angeles Meningococcal Infection in Chicago Meningococcal Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease